5-STAR CMS RATING

Our Navitus MedicareRx Employer Group Waiver Plan (EGWP) has received a 5 out of 5 Overall Star Rating from the Centers for Medicare & Medicaid Services (CMS). This rating applies to plan year 2017. Click here to read more about what this rating means for EGWP plan sponsors and members.

On February 9, 2017

Exela Pharma Sciences, in association with marketer X-Gen Pharmaceuticals, Inc., is voluntarily recalling lot number PLND1613 of Ibuprofen Lysine Injection, 20 mg /2 mL (10 mg/mL), vials to the hospital or user level.

about this drug recall >
On January 24, 2017

Hospira, Inc. voluntarily recalled one lot of vancomycin Hcl for Injection drug. Hospira Inc. is a Pfizer Company. It recalled the drug because some vials may have solid particles in them.

about this drug recall >
On September 14, 2016

Virtus Pharmaceuticals Opco II, LLC is voluntarily recalling 7 batches of Hyoscyamine sulfate 0.125mg to the consumer level which include the tablet, sublingual, and orally disintegrating tablet form.

about this drug recall >

This plan, Navitus MedicareRx (PDP), is offered by Navitus Health Solutions and underwritten by Dean Health Insurance, Inc., A Federally-Qualified Medicare Contracting Prescription Drug Plan.